?? |
?? ?? |
CAS |
MF |
![Skepinone-L](/CAS/20150408/GIF/1221485-83-1.gif) |
Skepinone-L |
1221485-83-1 |
C24H21F2NO4 |
![LY2228820](/CAS/20150408/GIF/862507-23-1.gif) |
LY2228820 |
862507-23-1 |
C26H37FN6O6S2 |
![VX 702](/CAS/GIF/745833-23-2.gif) |
VX 702 |
745833-23-2 |
C19H12F4N4O2 |
![PH 797804](/CAS/GIF/586379-66-0.gif) |
PH 797804 |
586379-66-0 |
C22H19BrF2N2O3 |
![(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE](/CAS/GIF/658084-64-1.gif) |
(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE |
658084-64-1 |
C24H29N3O2 |
![E-64C](/CAS/GIF/76684-89-4.gif) |
E-64C |
76684-89-4 |
C15H26N2O5 |
![CK-636](/CAS/20150408/GIF/442632-72-6.gif) |
CK-636 |
442632-72-6 |
C16H16N2OS |
![N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamidehydrochloride](/CAS/GIF/313553-47-8.gif) |
N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamidehydrochloride |
313553-47-8 |
C18H16N2OS |
![[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone](/CAS/GIF/1000669-72-6.gif) |
[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone |
1000669-72-6 |
C20H20N4O |
![TCS 359](/CAS/GIF/301305-73-7.gif) |
TCS 359 |
301305-73-7 |
C18H20N2O4S |
![6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine](/CAS2/GIF/934353-76-1.gif) |
6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine |
934353-76-1 |
C21H25N7 |
![CX-5461](/CAS/20150408/GIF/1138549-36-6.gif) |
CX-5461 |
1138549-36-6 |
C27H27N7O2S |
![YK-4-279](/CAS/20180713/GIF/1037184-44-3.gif) |
YK-4-279 |
1037184-44-3 |
C17H13Cl2NO4 |
![Dexmedetomidine](/CAS/GIF/113775-47-6.gif) |
Dexmedetomidine |
113775-47-6 |
C13H16N2 |
![Diphemanil Methylsulfate](/CAS/GIF/62-97-5.gif) |
Diphemanil Methylsulfate |
62-97-5 |
C20H24N.CH3O4S |
![BRL 54443](/StructureFile/ChemBookStructure4/GIF/CB2690838.gif) |
BRL 54443 |
57477-39-1 |
C14H18N2O |
![TAK-632](/CAS/20150408/GIF/1228591-30-7.gif) |
TAK-632 |
1228591-30-7 |
C27H18F4N4O3S |
![AZ 628](/CAS2/GIF/878739-06-1.gif) |
AZ 628 |
878739-06-1 |
C27H25N5O2 |
![NU1025](/CAS/GIF/90417-38-2.gif) |
NU1025 |
90417-38-2 |
C9H8N2O2 |
![IMD-0354](/CAS/GIF/978-62-1.gif) |
IMD-0354 |
978-62-1 |
C15H8ClF6NO2 |
![BAY 11-7085](/CAS/GIF/196309-76-9.gif) |
BAY 11-7085 |
196309-76-9 |
C13H15NO2S |
![PD318088](/CAS/20150408/GIF/391210-00-7.gif) |
PD318088 |
391210-00-7 |
C16H13BrF3IN2O4 |
![IWP-2](/CAS/GIF/686770-61-6.gif) |
IWP-2 |
686770-61-6 |
C22H18N4O2S3 |
![AZD5363](/CAS/20150408/GIF/1143532-39-1.gif) |
AZD5363 |
1143532-39-1 |
C21H25ClN6O2 |
![BMN 673](/CAS/20150408/GIF/1207456-01-6.gif) |
BMN 673 |
1207456-01-6 |
C19H14F2N6O |
![ICG-001](/CAS/GIF/780757-88-2.gif) |
ICG-001 |
780757-88-2 |
C33H32N4O4 |
![Onalespib](/CAS/GIF/912999-49-6.gif) |
Onalespib |
912999-49-6 |
C24H31N3O3 |
![PJ-34](/StructureFile/ChemBookStructure6/GIF/CB3434387.gif) |
PJ-34 |
344458-19-1 |
C17H17N3O2 |
![TPCA-1](/CAS/GIF/507475-17-4.gif) |
TPCA-1 |
507475-17-4 |
C12H10FN3O2S |
![SL 327](/CAS/GIF/305350-87-2.gif) |
SL 327 |
305350-87-2 |
C16H12F3N3S |
![6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide](/CAS2/GIF/801312-28-7.gif) |
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide |
801312-28-7 |
C27H26N4O5S |
![5-(2-Oxo-2-phenylethoxy)-3,4-dihydroisoquinolin-1(2H)-one](/CAS/GIF/1048371-03-4.gif) |
5-(2-Oxo-2-phenylethoxy)-3,4-dihydroisoquinolin-1(2H)-one |
1048371-03-4 |
C17H13NO3 |
![6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine](/CAS/GIF/873436-91-0.gif) |
6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine |
873436-91-0 |
C18H21IN6O2S |
![TAK-733](/CAS/20150408/GIF/1035555-63-5.gif) |
TAK-733 |
1035555-63-5 |
C17H15F2IN4O4 |
![4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide](/CAS/GIF/908112-43-6.gif) |
4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide |
908112-43-6 |
C23H27F3N4O3 |
![BIX 02189](/CAS/GIF/1094614-85-3.gif) |
BIX 02189 |
1094614-85-3 |
C27H28N4O2 |
![A-674563](/CAS/GIF/552325-73-2.gif) |
A-674563 |
552325-73-2 |
C22H22N4O |
![PF-04929113](/CAS/20150408/GIF/908115-27-5.gif) |
PF-04929113 |
908115-27-5 |
C25H30F3N5O4 |
![S- (+)-Rolipram](/CAS/GIF/85416-73-5.gif) |
S- (+)-Rolipram |
85416-73-5 |
C16H21NO3 |
![FH 535](/CAS/GIF/108409-83-2.gif) |
FH 535 |
108409-83-2 |
C13H10Cl2N2O4S |
![PHT-427](/CAS/GIF/1191951-57-1.gif) |
PHT-427 |
1191951-57-1 |
C20H31N3O2S2 |
![Wnt-C59](/CAS/20150408/GIF/1243243-89-1.gif) |
Wnt-C59 |
1243243-89-1 |
C25H21N3O |
![AZD2461](/CAS/GIF/1174043-16-3.gif) |
AZD2461 |
1174043-16-3 |
C22H22FN3O3 |
![1-AZAKENPAULLONE](/CAS/GIF/676596-65-9.gif) |
1-AZAKENPAULLONE |
676596-65-9 |
C15H10BrN3O |
![Imidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one, 2-[4-[(dimethylamino)methyl]phenyl]-5,6-dihydro-](/CAS/GIF/328543-09-5.gif) |
Imidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one, 2-[4-[(dimethylamino)methyl]phenyl]-5,6-dihydro- |
328543-09-5 |
C19H20N4O |
![KW-2478](/CAS/20150408/GIF/819812-04-9.gif) |
KW-2478 |
819812-04-9 |
C30H42N2O9 |
![U0126-EtOH](/CAS/20211123/GIF/1173097-76-1.gif) |
U0126-EtOH |
1173097-76-1 |
C20H22N6OS2 |
![Fenspiride hydrochloride](/CAS/GIF/5053-08-7.gif) |
Fenspiride hydrochloride |
5053-08-7 |
C15H21ClN2O2 |
![SC-514](/CAS/GIF/354812-17-2.gif) |
SC-514 |
354812-17-2 |
C9H8N2OS2 |
![IWR-1-endo](/CAS/GIF/1127442-82-3.gif) |
IWR-1-endo |
1127442-82-3 |
C25H19N3O3 |
![CCT128930](/CAS/GIF/885499-61-6.gif) |
CCT128930 |
885499-61-6 |
C18H20ClN5 |
![Binimetinib](/CAS/GIF/606143-89-9.gif) |
Binimetinib |
606143-89-9 |
C17H15BrF2N4O3 |
![KY0211](/CAS/20150408/GIF/1118807-13-8.gif) |
KY0211 |
1118807-13-8 |
C18H17ClN2O3S |
![Salirasib](/CAS/GIF/162520-00-5.gif) |
Salirasib |
162520-00-5 |
C22H30O2S |
![ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE](/CAS/GIF/869363-13-3.gif) |
ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE |
869363-13-3 |
C25H15ClF2N4O2 |
![CYC-116](/CAS/20180713/GIF/693228-63-6.gif) |
CYC-116 |
693228-63-6 |
C18H20N6OS |
![CCT129202](/CAS/GIF/942947-93-5.gif) |
CCT129202 |
942947-93-5 |
C23H25ClN8OS |
![PF-03814735](/CAS/GIF/942487-16-3.gif) |
PF-03814735 |
942487-16-3 |
C23H25F3N6O2 |
![1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide](/CAS/GIF/1396772-26-1.gif) |
1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
1396772-26-1 |
C32H37N5O3 |
![UNC 1999](/CAS/20150408/GIF/1431612-23-5.gif) |
UNC 1999 |
1431612-23-5 |
C33H43N7O2 |
![UNC 0631](/CAS/20150408/GIF/1320288-19-4.gif) |
UNC 0631 |
1320288-19-4 |
C37H61N7O2 |
![LY310762](/CAS/GIF/192927-92-7.gif) |
LY310762 |
192927-92-7 |
C24H27O2N2FHCl |
![2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride](/CAS/GIF/694433-59-5.gif) |
2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride |
694433-59-5 |
C20H21N3O2 |
![Hesperadin](/CAS/GIF/422513-13-1.gif) |
Hesperadin |
422513-13-1 |
C29H32N4O3S |
![LY2090314](/CAS/20150408/GIF/603288-22-8.gif) |
LY2090314 |
603288-22-8 |
C28H25FN6O3 |
![2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)-](/CAS/GIF/404951-53-7.gif) |
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- |
404951-53-7 |
C22H25N3O3 |
![ZOTAROLIMUS](/CAS/GIF/221877-54-9.gif) |
ZOTAROLIMUS |
221877-54-9 |
C52H79N5O12 |
![JAK3 Inhibitor](/CAS/GIF/211555-04-3.gif) |
JAK3 Inhibitor |
211555-04-3 |
C16H14BrN3O3 |
![N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea](/CAS2/GIF/1144068-46-1.gif) |
N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea |
1144068-46-1 |
C27H33N7O4 |
![N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea](/CAS/GIF/1207360-89-1.gif) |
N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
1207360-89-1 |
C24H32N6O3 |
![PFI-1](/CAS/GIF/1403764-72-6.gif) |
PFI-1 |
1403764-72-6 |
C16H17N3O4S |
![2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO-](/CAS/GIF/252935-94-7.gif) |
2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO- |
252935-94-7 |
C20H17Cl2N9O2 |
![4SC-201](/CAS/20150408/GIF/864814-88-0.gif) |
4SC-201 |
864814-88-0 |
C16H19N3O4S |
![GLPG0634](/CAS/20150408/GIF/1206101-20-3.gif) |
GLPG0634 |
1206101-20-3 |
C23H18N6O2 |
![JNJ-26481585](/CAS/GIF/875320-29-9.gif) |
JNJ-26481585 |
875320-29-9 |
C21H26N6O2 |
![GSK 525762A](/CAS/20150408/GIF/1260907-17-2.gif) |
GSK 525762A |
1260907-17-2 |
C22H22ClN5O2 |
![PI3K/HDAC Inhibitor](/CAS/GIF/1339928-25-4.gif) |
PI3K/HDAC Inhibitor |
1339928-25-4 |
C23H24N8O4S |
![9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one](/CAS/GIF/1223001-51-1.gif) |
9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one |
1223001-51-1 |
C24H15F3N4O |
![Torin 1](/CAS/GIF/1222998-36-8.gif) |
Torin 1 |
1222998-36-8 |
C35H28F3N5O2 |
![Filgotinib](/CAS/GIF/1206161-97-8.gif) |
Filgotinib |
1206161-97-8 |
C21H23N5O3S |
![PCI 34051](/CAS/GIF/950762-95-5.gif) |
PCI 34051 |
950762-95-5 |
C17H16N2O3 |
![BRL 15572 HYDROCHLORIDE](/CAS/GIF/193611-72-2.gif) |
BRL 15572 HYDROCHLORIDE |
193611-72-2 |
C25H28Cl2N2O |
![GSK 343](/CAS/20150408/GIF/1346704-33-3.gif) |
GSK 343 |
1346704-33-3 |
C31H39N7O2 |
![SCRIPTAID](/CAS/GIF/287383-59-9.gif) |
SCRIPTAID |
287383-59-9 |
C18H18N2O4 |
![tasquinimod](/CAS/20150408/GIF/254964-60-8.gif) |
tasquinimod |
254964-60-8 |
C20H17F3N2O4 |
![Ziprasidone](/CAS/GIF/122883-93-6.gif) |
Ziprasidone |
122883-93-6 |
C21H21ClN4OS |
![Aurora A Inhibitor I](/CAS2/GIF/1158838-45-9.gif) |
Aurora A Inhibitor I |
1158838-45-9 |
C31H31ClFN7O2 |
![MK-5108 (VX-689)](/CAS/20180713/GIF/1010085-13-8.gif) |
MK-5108 (VX-689) |
1010085-13-8 |
C22H21ClFN3O3S |
![CCT 137690](/CAS/GIF/1095382-05-0.gif) |
CCT 137690 |
1095382-05-0 |
C26H31BrN8O |
![AZD 1080](/CAS/20150408/GIF/612487-72-6.gif) |
AZD 1080 |
612487-72-6 |
C19H18N4O2 |
![SB 415286](/CAS/GIF/264218-23-7.gif) |
SB 415286 |
264218-23-7 |
C16H10ClN3O5 |
![AR-42](/CAS/GIF/935881-37-1.gif) |
AR-42 |
935881-37-1 |
C18H20N2O3 |
![AMG 900](/CAS/GIF/945595-80-2.gif) |
AMG 900 |
945595-80-2 |
C28H21N7OS |
![WP1066](/CAS/GIF/857064-38-1.gif) |
WP1066 |
857064-38-1 |
C17H14BrN3O |
![?????](/CAS/GIF/937272-79-2.gif) |
????? |
937272-79-2 |
C28H32N4O3 |
![Tazemetostat (EPZ-6438)](/CAS/20150408/GIF/1403254-99-8.gif) |
Tazemetostat (EPZ-6438) |
1403254-99-8 |
C34H44N4O4 |
![4-(4-FLUORO-1-NAPHTHALENYL)-6-(1-METHYLETHYL)-2-PYRIMIDINAMINE HYDROCHLORIDE](/CAS/GIF/199864-87-4.gif) |
4-(4-FLUORO-1-NAPHTHALENYL)-6-(1-METHYLETHYL)-2-PYRIMIDINAMINE HYDROCHLORIDE |
199864-87-4 |
C17H16FN3 |
![WYE-354](/CAS/GIF/1062169-56-5.gif) |
WYE-354 |
1062169-56-5 |
C24H29N7O5 |
![5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine](/CAS/GIF/1224844-38-5.gif) |
5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
1224844-38-5 |
C15H15N7O |
![EPZ004777](/CAS/20150408/GIF/1338466-77-5.gif) |
EPZ004777 |
1338466-77-5 |
C28H41N7O4 |